A Study of the Effects of Advantage 24 on the Rectum

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1999

Conditions
HIV Infections
Interventions
DRUG

Nonoxynol-9

Trial Locations (1)

98104

Univ of Washington, Seattle

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000929 - A Study of the Effects of Advantage 24 on the Rectum | Biotech Hunter | Biotech Hunter